Rockville biotech RegenxBio launches clinical trial in muscular dystrophy

It's one of a series of treatments the company is developing as it aims to bring multiple products to market by 2025.

Source: bizjournals.com Health Care:Biotechnology headlines - January 23, 2023 Category: Biotechnology Authors: Sara Gilgore Source Type: news